Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS10020428
Proximate region of VIS (GRCh38)
VIS
Enhancer
Enhancer/Promoter
Promoter
Gene
120678213
120735623
120992653
120785111
120789067
120804710
120808132
120865735
120868905
120861510
120864454
120819474
120821891
120825252
120827484
120792873
120795068
120817694
120819219
120858427
120859915
120847100
120848541
120884911
120886092
120801989
120803129
120834909
120835957
120866378
120867403
120874625
120875478
120795933
120796767
120797336
120798163
120882014
120882662
120873776
120874289
120845383
120845879
120852507
120852993
120798492
120798912
120865204
120865535
120803499
120803816
120843109
120843399
120856084
120856316
120791965
120792194
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10020428
Fusion event
HBV-GLI2 integration
Validated
No
Detection method
VirusScan
Data source
Curated
Sample type
Tumor
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Good
Reported year
2016
PubMed ID
27339696
Virus Sequence
Virus name
HBV
Reference genome
NC_003977.1
Start
1
End
1045
Orient
+
Integrated sequence
TCCACAACATTCCACCAAGCTCTGCTAGATCCCAGAGTGAGGGGCCTATATTTTCCTGCTGGTGGCTCCAGTTCCGGAACAGTAAACCCTGTTCCGACTACTGCCTCACCCATATCGTCAATCTTCTCGAGGACTGGGGACCCTGCACCGAACATGGAGAGCACAACATCAGGATTCCTAGGACCCCTGCTCGTGTTACAGGCGGGGTTTTTCTTGTTGACAAGAATCCTCACAATACCACAGAGTCTAGACTCG
Host Sequence
Chromosome
chr2
Cytoband
q14.2
Reference genome
GRCh37/hg19
Start
121592484/120834909 (Hg38)
End
121593532/120835957 (Hg38)
Orient
+
Location type
Intronic
Fragile sites / regions
FRA2S
Target gene
GLI2
miRNAs that regulate target gene
hsa-mir-1-3p
;
hsa-mir-26b-5p
;
hsa-mir-31-5p
;
hsa-mir-218-5p
;
hsa-mir-574-5p
;
hsa-mir-5572
;
hsa-mir-4260
;
hsa-mir-450a-2-3p
;
hsa-mir-6855-5p
;
hsa-mir-3170
;
hsa-mir-6819-5p
;
hsa-mir-6812-5p
;
hsa-mir-6737-5p
;
hsa-mir-6740-5p
;
hsa-mir-6867-5p
;
hsa-mir-3650
;
hsa-mir-4455
;
hsa-mir-6747-5p
;
hsa-mir-608
;
hsa-mir-4651
;
hsa-mir-4664-5p
;
hsa-mir-342-5p
;
hsa-mir-4748
;
hsa-mir-4464
;
hsa-mir-466
;
hsa-mir-6793-3p
;
hsa-mir-4643
;
hsa-mir-4789-3p
;
hsa-mir-95-5p
;
hsa-mir-223-5p
;
hsa-mir-541-3p
;
hsa-mir-654-5p
;
hsa-mir-6769a-5p
;
hsa-mir-6769b-5p
;
hsa-mir-92a-2-5p
Nearest miRNA
hsa-mir-1285-2/Upstream/7113541; hsa-mir-10b/Downstream/6587580;
Nearest TSS
ENST00000437798/Upstream/37564;
ENST00000432984/Downstream/31446;
Nearest CpG islands
None/Target,
chr2-CpG: 135/Upstream/92907
,
chr2-CpG: 23/Downstream/31458
Nearest cancer related gene
GLI2
(OG, No orient, 0)
Upstream sequence
GCAGCTATTTCATTTCAATGACAGATGGCTGGTTTTCTACTTTTGTTTTGTTTTCTGTGTATTACTTCAAACATAAAATACAGGCTTACCTTAACTTTTT
Downstream sequence
atgcagacattagggagtgtgcattgtttatagagaattcaaaagcaataatcaaactggctaacagtttactatatgttattactatgtcctggcaatt
Target sequence
GCACCCCATGTTCTCTGGGCTAAACCCACATGGGTCCTCACTCTTCAGCTCGTTTTCCACTGTTTGTGTGCGACATTTGGGTGGAGTTGTGACCAGGCAGCCTTATCATTTTTGGAGCAAACATTACTATTTTGATAAATTGACTGGTTTTTGACAAACACACCAAACTGAAAAAAAGACAATCTCTCTGAGGGAAGGAAAGTGATCATCAAACAGTGAAGACCAGGATTTGGGGGTGGTATGGGTGGAGCCAAT
Reference
Cao, S., et al.Divergent viral presentation among human tumors and adjacent normal tissues. Sci Rep,2016, 6: 28294.
Sample Information
×
Sample name
TCGA-DD-A1EA-01A-11R-A131-07
Sample type
Tumor
Gender
Female
CpG Island Information
×
Download
Curate